Ken Griffin Icad Inc Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1.19 - $1.74 $357 - $522	-300 Reduced 50.0%	300 $0
Q2 2024 Aug 14, 2024	SELL	$1.28 - $1.9 $9,344 - $13,870	-7,300 Reduced 92.41%	600 $0
Q1 2024 May 15, 2024	SELL	$1.35 - $2.27 $270 - $454	-200 Reduced 2.47%	7,900 $12,000
Q4 2023 Feb 14, 2024	BUY	$1.27 - $2.06 $8,382 - $13,596	6,600 Added 440.0%	8,100 $14,000
Q3 2023 Nov 14, 2023	BUY	$1.8 - $3.61 $2,700 - $5,415	1,500 New	1,500 $3,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.84 $7,800 - $18,460	-6,500 Reduced 75.58%	2,100 $2,000
Q4 2022 Feb 14, 2023	SELL	$1.6 - $2.37 $2,400 - $3,555	-1,500 Reduced 14.85%	8,600 $15,000
Q3 2022 Nov 14, 2022	BUY	$2.04 - $4.32 $20,604 - $43,632	10,100 New	10,100 $21,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.